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Abstract
A 34-year-old woman was admitted to our emergency room with a high fever, abdominal pain,
dyspnea and confusion. High fever and abdominal pain had first occured after a cystocele oper-
ation 5 months earlier. Later, congestive heart failure with mural thrombus formation, peripheral
polyneuropathy and ischemic cerebrovascular accident were identified in clinical follow-ups, and
multiple arterial and venous thromboses were seen on cranial and abdominal magnetic resonance
imaging angiography. The patient’s symptoms improved with anticoagulant treatment. Antiphos-
pholipid syndrome with elevated serum anticardiolipin IgG levels was diagnosed, and ischemic
peripheral polyneuropathy with axonal degeneration was determined by sural nerve biopsy. In
antiphospholipid syndrome, elevated anticardiolipin antibodies appear to be the most common ac-
quired blood protein defect causing thrombosis. Disseminated vascular thrombosis in catastrophic
antiphospholipid syndrome can result in multiorgan failure with increased morbidity and mortality.
It rarely occurs secondary to various infections as in the case of our patient, who suffered postoper-
ative intraabdominal infection. It is important to note that peripheral nervous system involvement
is rare in antiphospholipid syndrome.
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A 34-year-old woman was admitted to our emergency room with a high fever, abdominal pain,
dyspnea and confusion. High fever and abdominal pain had ﬁrst occured after a cystocele operation 5 months earlier. Later, congestive heart failure with mural thrombus formation, peripheral polyneuropathy and ischemic cerebrovascular accident were identiﬁed in clinical follow-ups, and multiple arterial and venous thromboses were seen on cranial and abdominal magnetic resonance imaging angiography. The patient’s symptoms improved with anticoagulant treatment. Antiphos-
pholipid syndrome with elevated serum anticardiolipin IgG levels was diagnosed, and ischemic peripheral polyneuropathy with axonal degeneration was determined by sural nerve biopsy. In antiphospholipid syndrome, elevated anticardiolipin antibodies appear to be the most common acquired blood protein defect causing thrombosis. Disseminated vascular thrombosis in catastrophic antiphospholipid syndrome can result in multiorgan failure with increased morbidity and mortality.
It rarely occurs secondary to various infections as in the case of our patient, who suﬀered postoperative intraabdominal infection. It is important to note that peripheral nervous system involvement is rare in antiphospholipid syndrome.
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I n order for thrombus formation to occur,multiple preliminary factors ﬁrst mentioned by Virchow at the beginning of the last century must be present［1］.
Today it is deﬁned as the end-point of several pathologic processes rather than as a disease, and it is known to occur secondary to other systemic diseases or prethrom-
botic events. Antiphospholipid syndrome, a systemic disorder characterized by arterial and venous thrombosis,
can be either primary or secondary to connective tissue diseases, vasculitis or infections, or may be triggered by
 
the use of any of several drugs. In the present report, we discuss the case of a patient with antiphospholipid syn-
drome which occured secondary to intraabdominal sur-
gery and/or postoperative infection and which was com-
plicated by multiorgan failure due to disseminated arterial and venous thrombosis.
Case Report
 
A 34-year-old woman was admitted to our emergency room with a high fever, abdominal pain, dyspnea,
weakness and confusion. The abdominal pain and high fever had ﬁrst occured after a cystocele operation 5 months earlier and were interpreted as post-operative
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intraabdominal infection. Her symptoms recurred despite intravenous antibiotic treatment. Symptoms and signs of peripheral polyneuropathy and congestive heart failure developed later and right pleural eﬀusion was found upon further examination.
The patient was in a somnolent state with a body temperature of 38.1°C and a blood pressure of 160/110 mmHg bilaterally. Physical examination revealed tachy-
pnea, tachycardia, peripheral cyanosis, bilateral cervical venous dilatation, positive hepato-jugular reﬂux, midsys-
tolic ejection murmur and third heart sound heard on precordium, ecchymosis around the umblicus, general-
ized abdominal tenderness without defence and rebound tenderness, hepatomegaly, percussable spleen, erythema and tenderness of the left crura, muscular weakness more prominent at the distal extremities that severely impeded her movements, peripheral sensory neuropathy and bilat-
eral decreased deep tendon reﬂexes.
In laboratory examination, the patient’s erythrocyte sedimentation rate was 24 mm/h and a complete blood count showed total leukocytes 23,000/mm?, neutrophils 22,000/mm?, lymphocytes 1,000/mm?, hemoglobin 111 g/L, hematocrits 35 , erythrocyte mean corpuscular volume 89 fL, and thrombocytes 83,000/mm?. Serum biochemical analysis revealed sodium 128 mmol/L,
potassium 3.3 mmol/L, alanine aminotransferase 130 IU/L, aspartate aminotransferase 72 IU/L, gamma glutamyl transferase 88 IU/L, albumin 21.1 g/L, and gamma globulin 18.1 g/L. Sinus tachycardia with invert-
ed T waves on all derivations was seen on electrocardio-
graphy. Urine sediment was abundant with red blood cells and was thought to be related to the patient’s intraurethral catheter. Left atrial dilatation, decreased left ventricular systolic function with 2 mural thrombi and moderate mitral valve insuﬃciency were seen on echocardiography.
The patient’s left ventricular ejection fraction was 32 .
Hypoperfusion in the inferior-basal segments of the left ventricule was seen in a Thallium-201 scan. Percutaneous transfemoral coronary angiography was normal;blood cultures were sterile. Intravenous unfractionated heparin 5,000 units bolus and 1,000 units/h infusion was begun.
Right hemiplegia and coma developed after the ﬁrst day of the heparin infusion. No intracranial hemorrhage was found on cranial computed tomography. Cranial magnetic resonance imaging (MRI)indicated multiple cerebral and cerebellar infarcts and suspicious contrast diﬀerences on the left transverse and sigmoid sinuses, possibly related to impeded blood ﬂow or thrombus formation. After 3
 
days of heparin treatment, the patient regained conscious-
ness. Anticoagulant treatment was continued with warfa-
rin. Neurologic examination showed right hemiparesis,
bilateral motor and sensory polyneuropathy and decreased deep tendon reﬂexes, and electromyography revealed mononeuropathy multiplex with severe axonal degenera-
tion. During the warfarin treatment, prothrombin time was 18.2 sec, activated partial thromboplastin time was 78 sec and lupus anticoagulant was negative. Anticar-
diolipin IgG was 27 GPL U/mL(normal:＜13.3 GPL U/mL)and anticardiolipin IgM was 3.6 MPL U/mL
(normal:＜9.8 MPL U/mL). Antiphospholipid syn-
drome was diagnosed. Serum anti-nuclear antibody,
anti-double-stranded DNA antibody and anti-neutrophil cytoplasmic antibody were all negative. Cranial and abdominal MRI angiography showed decreased left trans-
verse sinus calibration, absent ﬂow in the left sigmoid sinus and left proximal jugular vein, and decreased blood ﬂow with thrombus formation in the abdominal aorta.
Sural nerve biopsy was performed and we identiﬁed severe axonal neuropathy with perivascular inﬂammation related to Wallerian degeneration caused by ischemic neuropathy.
Discussion
 
High fever, postoperative abdominal pain, leu-
kocytosis with neutrophilic predominance, throm-
bocytopenia and later rapid progression of multiorgan failure suggest sepsis and disseminated intravascular coagulation［2］. In the present case, however, serum levels of ﬁbrinogen and ﬁbrin degradation products were normal and there were no fragmented erythrocytes seen on a peripheral blood smear.
Hypoxemia and peripheral cyanosis were deemed to be related to severe heart failure due to the dilated car-
diomyopathy seen on echocardiography. Intramural thrombus formation might depend on the presence of a myocardial contractility disorder. Although hypoper-
fusion was found in the inferior-basal segments on a Thallium-201 scan, the patient’s coronary angiography was normal. Collagen/vascular diseases with myocardium involvement such as systemic lupus erythematosus and polyarteritis nodosa were used in diﬀerential diagnosis.
Ischemic vasculitic involvement of the vaso nervorum is responsible for 50  of cases with axonal degeneration in patients with polyarteritis nodosa, rheumatoid arthritis,
systemic lupus erythematosus or mixed connective tissue
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diseases. Other rare disorders are mixed cryo-
globulinemia, Sjo?gren’s syndrome, Wegener’s granulomatosis, amyloidosis and hypereosinophilic syn-
dromes［3］. After the identiﬁcation of multiple venous thrombosis in our patient’s central nervous system and abdominal aorta, diseases with an increased tendency to thrombosis were suspected. Antiphospholipid syndrome,
systemic lupus erythematosus, thromboangitis obliterans,
Behçet’s syndrome, Wegener’s granulomatosis and hyperhomocysteinemia are known disorders with an in-
creased tendency to arterial and venous thrombotic events. We rejected these possibilities, however,
because our patient’s serum autoantibodies were negative and no symptoms or signs of Behçet’s syndrome or thromboangitis obliterans were found. Her serum homocystein level was normal, though her serum anticar-
diolipin antibody IgG was elevated.
Anticardiolipin antibodies are strongly associated with an increased tendency to thrombosis and elevated serum levels are seen in antiphospholipid syndrome, systemic lupus erythematosus, primary Sjo?gren’s syndrome,
rheumatoid arthritis, temporal arteritis and other connec-
tive tissue diseases, some viral, bacterial and parasitic infections, lymphoproliferative disorders, chronic liver diseases and with the use of certain drugs［4］. In our patient, antiphospholipid syndrome was diagnosed based on our clinical and laboratory ﬁndings.
Disseminated microvascular thrombosis in cata-
strophic antiphospholipid syndrome can result in multi-
organ failure and increased morbidity and mortality［5］.
Acute cerebrovascular accident, chronic dementia,
cognitive disorders, psychosis, chorea, epilepsy and transverse myelitis can be seen in cases of central nervous system involvement. Although these conditions are pre-
dominantly related to focal central nervous system thrombo-occlusive events, an interaction between anticar-
diolipin antibodies and central nervous system cellular elements may also be responsible for some of these disorders［6］. In the case of our patient, both central nervous system involvement and peripheral polyneu-
ropathy were found. Perivascular inﬂammation of the vaso nervosum and axonal degeneration were seen in sural nerve biopsy, possibly caused by microvascular throm-
botic events in the vaso nervorum due to ischemic neuropathy and axonal degeneration. It is important to note that peripheral nervous system involvement is rarely seen in antiphosholipid syndrome［7］.
Cardiac involvement consists valvular lesions and vegetations, intramural thrombi, coronary artery disease and cardiac failure. Dilated cardiomyopathy is known to be related to microthrombi in the absence of valvular lesions or coronary artery disease［8, 9］. Intramural thrombus formation might be caused by dilated car-
diomyopathy and/or an increased tendency to thrombosis.
Mesenteric ischemia and renal arterial stenosis could explain our patient’s abdominal pain and hypertension.
In conclusion, like a primary disorder, secondary antiphospholipid syndrome can involve many organ sys-
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Fig.1  Perivascular and transmural mononuclear inﬁltration in an epineurial vessel. Longitudinal paraﬃn section 10×10. Bar indicates 200μm.
Fig. 2  Epineurial vessel showing recanalization. Transverse paraﬃn section 20×10. Bar indicates 100μm.
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tems such as the cardiovascular and central nervous systems. It is important to note that peripheral nervous system involvement is rarely seen in cases of secondary antiphospholipid syndrome. Oral anticoagulation is the treatment of choice. In our patient, symptoms and signs were improved with warfarin alone, and after two years of clinical follow-up, no recurrence was reported under this treatment.
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Table 1  Laboratory examination results?
Hgb  111 g/L  Total Protein  56.7 g/L Hct  35% Albumin  21.1 g/L MCV  89 fL γ-globulin  18.1 g/L WBC  23000/mm? Glucosuria  Negative PMNL  22000/mm? Proteinuria  Negative Lymphocytes 1000/mm? Urine sedimentation  
Microscopic hematuria PLT  83000/mm? PT  18.2 sec(Warfarin tx)
BUN  7.854 mmol/L aPTT  78 sec Creatinine  88.4μmol/L Lupus anticoagulant  
Negative
 
Na  128 mmol/L ACL IgG  27 GPL U/mL K  3.3 mmol/L  ACL IgM  3.6 MPL U/mL Cl  96 mmol/L  ANA  Negative ALT  130 IU/L  Anti ds DNA  Negative AST  72 IU/L  ANCA  Negative GGT  88 IU/L  ESR  24 mm/h ALP  216 IU/L  Serum homocystein  
8.7μmol/L
 
ACL IgG,anti cardiolipin antibody IgG;ACL IgM,anticardiolipin IgM;ALP,
alkaline phosphatase;ALT,alanine amino transferase;ANA,anti-nuclear antibody;ANCA,anti-neutrophil cytoplasmic antibody;Anti ds DNA, anti-
double-stranded DNA;aPTT, activated partial thromboplastin time;AST,
aspartate aminotransferase;BUN,blood-urine-nitrogen;Cl,chloride;ESR,
erythrocyte sedimentation rate;γ-globulin,gamma-globulin;GGT,gamma-
glutamyl transferase;Hgb, hemoglobin;Hct, hematocrits;K, potassium;
MCV, mean corpuscular volume; Na,sodium;PLT, platelets;PMNL,
polymorphonuclear leukocytes;PT, prothrombin time;WBC,white blood cells.
?Laboratory examination of the patient revealed neutrophilic leukocytosis,
mild elevation of liver transaminases, hypoalbuminemia and increased aPTT and serum ACL IgG levels consistent with antiphospholipid syndrome.
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